Profile
| Metric | Value |
|---|---|
| Full Name | Disc Medicine, Inc. |
| Ticker | NASDAQ: IRON |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | discmedicine.com |
| Employees | 94 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $77.08 | |
| Price, 1D Change | +2.17% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.24 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$3.96 | |
| EPS, 1Y Change | -15.66% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | GMTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$3.96 | |
| EPS Estimate | -$5.96 | |
| EPS Est. Change | -50.51% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $77.08 | |
| Price Target | - | $117.50 |
| Price Tgt. Change | - | +52.44% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.28 | -$3.42 | -4.42% | |
| -$4.08 | -$3.96 | +2.95% | |
| -$5.96 | N/A | -50.51% | |
| -$6.59 | N/A | -66.27% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $47.42M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +27.47% | |
| Price, 3Y | +300.42% | |
| Market Cap, 1Y | +61.12% | |
| Market Cap, 3Y | +768.44% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -15.66% | |
| EPS, 3Y | +90.33% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $77.08 | |
| SMA 200 | $64.41 | |
| SMA 200 vs Price | -16.44% | |
| SMA 50 | $86.27 | |
| SMA 50 vs Price | +11.93% | |
| Beta | 1.24 | |
| ATR | $3.61 | |
| 14-Day RSI | 39.59 | |
| 10-Day Volatility | 43.65% | |
| 1-Year Volatility | 51.39% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$3.96 | |
| Gross Profit | -$156.00K | |
| - | ||
| Operating Profit | -$129.72M | |
| - | ||
| Net Income | -$109.36M | |
| - | ||
| EBITDA | -$129.56M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.07 | |
| Current Ratio | 21.17 | |
| Quick Ratio | 21.17 | |
| Interest Coverage | - | |
| - | ||
| Altman Z-Score | 32.26 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | - | |
| PB Ratio | 5.07 | |
| EV/EBITDA | -11.43 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $443.59M | |
| Cash & Equivalents | $192.43M | |
| Total Assets | $496.77M | |
| Current Assets | $493.62M | |
| Total Liabilities | $53.19M | |
| Current Liabilities | $23.32M | |
| Total Debt | $30.00M | |
| Short Term Debt | $130.00K | |
| Accounts Payable | $7.95M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $109.36M | |
| Operating Expenses | $129.56M | |
| Cost Of Goods Sold | $156.00K | |
| SG&A | $33.05M | |
| D&A | $156.00K | |
| Interest Expense | $0.00 | |
| Income Tax | $355.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | -$93.93M | |
| CFI | -$292.33M | |
| CFF | $218.31M | |
| Capex | $505.00K | |
| Free Cash Flow | -$94.43M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Truist Securities | → | |
| Morgan Stanley | → | |
| Wedbush | → | |
| Raymond James | → | |
| Cantor Fitzgerald | → | |
| Morgan Stanley | → | |
| Truist Securities | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with IRON
Data Sources & References
- IRON Official Website www.discmedicine.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1901203/000121390025096652/0001213900-25-096652-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1901203/000121390025015846/0001213900-25-015846-index.htm
- IRON Profile on Yahoo Finance finance.yahoo.com/quote/IRON
- IRON Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/iron
FAQ
What is the ticker symbol for Disc Medicine, Inc.?
The ticker symbol for Disc Medicine, Inc. is NASDAQ:IRON
Does Disc Medicine, Inc. pay dividends?
No, Disc Medicine, Inc. does not pay dividends
What sector is Disc Medicine, Inc. in?
Disc Medicine, Inc. is in the Healthcare sector
What industry is Disc Medicine, Inc. in?
Disc Medicine, Inc. is in the Biotechnology industry
What country is Disc Medicine, Inc. based in?
Disc Medicine, Inc. is headquartered in United States
When did Disc Medicine, Inc. go public?
Disc Medicine, Inc. initial public offering (IPO) was on August 12, 2020
Is Disc Medicine, Inc. in the S&P 500?
No, Disc Medicine, Inc. is not included in the S&P 500 index
Is Disc Medicine, Inc. in the NASDAQ 100?
No, Disc Medicine, Inc. is not included in the NASDAQ 100 index
Is Disc Medicine, Inc. in the Dow Jones?
No, Disc Medicine, Inc. is not included in the Dow Jones index
When was Disc Medicine, Inc. last earnings report?
Disc Medicine, Inc.'s most recent earnings report was on November 6, 2025
When does Disc Medicine, Inc. report earnings?
The next expected earnings date for Disc Medicine, Inc. is February 26, 2026